Clinical trials
Phase 3 Cardiovascular Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
329 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 5 |
| 2002 | 5 |
| 2003 | 10 |
| 2004 | 11 |
| 2005 | 11 |
| 2006 | 7 |
| 2007 | 11 |
| 2008 | 16 |
| 2009 | 10 |
| 2010 | 16 |
| 2011 | 12 |
| 2012 | 15 |
| 2013 | 6 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 6 |
| 2019 | 10 |
| 2020 | 9 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 10 |
| 2024 | 7 |
| 2025 | 9 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 230 |
| Terminated | 31 |
| Unknown status | 26 |
| Recruiting | 19 |
| Active, not recruiting | 13 |
| Withdrawn | 7 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 66 |
| Novartis Pharmaceuticals | 12 |
| Takeda | 12 |
| AstraZeneca | 7 |
| Eli Lilly and Company | 7 |
| GlaxoSmithKline | 6 |
| University of Washington | 6 |
| Brigham and Women's Hospital | 5 |
| University of California, San Francisco | 5 |
| Amgen | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 329 |
| Heart Diseases | 125 |
| Coronary Disease | 70 |
| Hypertension | 58 |
| Myocardial Ischemia | 58 |
| Myocardial Infarction | 54 |
| Vascular Diseases | 40 |
| Diabetes Mellitus | 25 |
| Heart Failure | 25 |
| Diabetes Mellitus, Type 2 | 21 |
Trials
Showing 76 to 100 of 329. Each trial links to its page on Pharma Observatory.
229 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.